Logo
x

Search

Subscribe Now

Treat

Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer

Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer

  • October 25, 2021
Gilead's Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA's Approval for Expanded Indication to Treat HIV-1

Gilead's Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) Low-Dose Tablet Receives the US FDA's Approval for Expanded In...

  • October 19, 2021
Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

  • October 13, 2021
Janssen Report Submission of sBLA to the US FDA for the Approval of Stelara (ustekinumab) to Treat Juvenile Psoriatic Arthritis

Janssen Report Submission of sBLA to the US FDA for the Approval of Stelara (ustekinumab) to Treat Juvenile Psoriatic Arthritis

  • October 11, 2021
Merck and Ridgeback Report EUA Submission to the US FDA for Molnupiravir to Treat COVID-19

Merck and Ridgeback Report EUA Submission to the US FDA for Molnupiravir to Treat COVID-19

  • October 11, 2021
Allogene Reports the US FDA's Clinical Hold on ALPHA2 Study of ALLO-501A to Treat Large B Cell Lymphoma

Allogene Reports the US FDA's Clinical Hold on ALPHA2 Study of ALLO-501A to Treat Large B Cell Lymphoma

  • October 8, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.